GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...

OPK's growth hinges on RAYALDEE and key partnerships, but rising competition and reliance on one drug pose risks.

Additionally, Opko Health remains focused on developing an oral GLP-1/glucagon tablet for NASH and obesity. The company forecasts total revenues for 2025 to range between $675 million and $685 ...

Additionally, Opko Health remains focused on developing an oral GLP-1/glucagon tablet for NASH and obesity. The company forecasts total revenues for 2025 to range between $675 million and $685 million ...

Denmark-based multinational pharmaceutical company Novo Nordisk will be making available in the Philippines within this year Wegovy, its approved weight loss treatment for ...

Tom Nolan reviews this week’s research Will cardiovascular disease prevention mostly be delivered by subcutaneous injection in the future? With increasing numbers of people starting tirzepatide and ...

Eli Lilly is a global healthcare giant, generating strong growth from a diverse portfolio of blockbuster medications. Viking Therapeutics has a weight-loss drug candidate VK2735, that aims to compete ...

A video showing a young child trying to wake her father up after his glucose levels go too low is making parents question ...

Switching to Humira biosimilars saved Navitus clients more than $315 million in upfront costs in 2024 and resulted in a 60% ...

Dizziness, sudden hunger, or easy anger? Could be a sign of low blood sugar. Recognize these 5 symptoms before it's too late!

It seems like just five or 10 years ago, the only people monitoring their blood sugar were those with diabetes who needed to ...

“Ozempic (semaglutide) is generally more effective for weight loss compared to Jardiance,” says the expert. Research, ...